{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:33Z","timestamp":1793633493198,"version":"4.5.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.lanepe.2026.101849","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:32:14Z","timestamp":1788553934000},"page":"101849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Designing eligibility and evaluation criteria for antibacterial pull incentives: a comparative review of implemented and emerging initiatives"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-4640","authenticated-orcid":false,"given":"Michael","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6391-4439","authenticated-orcid":false,"given":"Gunnar","family":"Ljungqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Cherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilke","family":"Claessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Schoefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8664-9297","authenticated-orcid":false,"given":"Elias","family":"Mossialos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2026.101849_bib1","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41591-024-03218-w","article-title":"Advancing global antibiotic research, development and access","volume":"30","author":"Piddock","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.lanepe.2026.101849_bib3","series-title":"How can the EU Support Sustainable Innovation and Access to effective antibiotics? Policy options for Existing and New Medicines","author":"Anderson","year":"2023"},{"key":"10.1016\/j.lanepe.2026.101849_bib4","article-title":"Challenges and opportunities for incentivising antibiotic research and development in Europe","volume":"33","author":"Anderson","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.lanepe.2026.101849_bib5","article-title":"Incentivising new antibiotics: designing a value-based delinked pull incentive mechanism","author":"Brassel","year":"2023","journal-title":"Contract Res"},{"key":"10.1016\/j.lanepe.2026.101849_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1377\/hlthaff.2021.00688","article-title":"Estimating the appropriate size of global pull incentives for antibacterial medicines","volume":"40","author":"Outterson","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.lanepe.2026.101849_bib11","author":"Aromataris"},{"key":"10.1016\/j.lanepe.2026.101849_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138237","article-title":"The role of google scholar in evidence reviews and its applicability to grey literature searching","volume":"10","author":"Haddaway","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lanepe.2026.101849_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst Rev"},{"key":"10.1016\/j.lanepe.2026.101849_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jclinepi.2022.05.022","article-title":"Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study","volume":"149","author":"Ewald","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2026.101849_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ja.2017.124","article-title":"Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps","volume":"70","author":"Simpkin","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.lanepe.2026.101849_bib17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/cid\/cix097","article-title":"Project bioshield and the biomedical advanced research development authority: a 10-Year progress report on meeting US preparedness objectives for threat agents","volume":"64","author":"Larsen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanepe.2026.101849_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.lanepe.2026.101849_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-020-02885-1","article-title":"Pharmaceuticals and environment: a web-based decision support for considering environmental aspects of medicines in use","volume":"76","author":"Ramstr\u00f6m","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lanepe.2026.101849_bib29","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1017\/S0266462324000552","article-title":"How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies","volume":"40","author":"Dumont","year":"2024","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.lanepe.2026.101849_bib31","author":"de Felice"},{"key":"10.1016\/j.lanepe.2026.101849_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.2130","article-title":"A decade in review: an analysis of the Qualified Infectious Disease Product (QIDP) designation","volume":"10","author":"Atillasoy","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanepe.2026.101849_bib43","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/14787210.2022.2142118","article-title":"A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future","volume":"20","author":"Ohashi","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.lanepe.2026.101849_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103485","article-title":"Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27","volume":"88","author":"Goh","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.lanepe.2026.101849_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/antibiotics11020200","article-title":"Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics","volume":"11","author":"Murugaiyan","year":"2022","journal-title":"Antibiotics"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:18:14Z","timestamp":1793632694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226002619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"alternative-id":["S2666776226002619"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101849","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing eligibility and evaluation criteria for antibacterial pull incentives: a comparative review of implemented and emerging initiatives","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101849"}}